Sender:
`
`Sent:
`Recipient:
`Cc:
`
`Subject:
`
`Edick Paul </O=CARTER-
`W ALLACE/OU=CRANMAILICN=RECIPIENTS/CN=EXCHANGE/CN=PEDICK>
`Monday, February 6, 2006 11:10:38 PM
`Fuge Dennis <dfuge@medpointepharma. com>
`D'Addio Alex <ADAddio@medpointepharma.com>;Spivey Richard
`<RSpi vey@medpointepharma.com>;Fishman Corey
`<CFishman@medpointepharma. com>; Coniglio Tony <tconigli o@medpointepharma. com>
`RE: Pfeiffer Bi Dose Nasal Spray System
`
`Thanks for the update. Agree on moving with formulation as best and fastest route.
`
`-----Original Message----(cid:173)
`From: Fuge Dennis
`Sent: Monday, February 06, 2006 5:57PM
`To: Edick Paul
`Cc: D'Addio Alex; Spivey Richard; Fishman Corey; Coniglio Tony
`Subject: RE: Pfeiffer Bi Dose Nasal Spray System
`
`Paul,
`Valois was in today and we had a very detailed presentation on the Pfeiffer Bi Dose and the Valois Dolphin.
`
`They are both syringe type nasal sprays that are designed to give two doses of the same formulation from a single chamber. Most of the
`applications are for the vaccine market where you want to give the vaccine in both nostrils. They will not work as dual chamber devices. The
`piston moves half way for the first shot and them the full way for the second shot. The Zomig nasal spray was the same device, but did not
`have the two spray feature built in.
`
`Rich, Alex and I have discussed the combo product and we all feel the shortest development route would be either a simple solution or a
`suspension, depending on the steroid used. That way we can use a multidose spray device such are the Equadel, VP7 or VP3 pumps.
`Regards,
`Dennis
`
`From: Edick Paul
`Sent: Saturday, January 28, 2006 I 0:57AM
`To: Fuge Dennis
`Cc: Fishman Corey; Spivey Richard; Coniglio Tony
`Subject: RE: Pfeiffer Bi Dose Nasal Spray System
`
`Dennis,
`
`We should put this on the front burner and pursue as exclusive for use in Rhinitis applications ASAP.
`
`Paul
`
`From: Fuge Dennis
`Sent: Friday, January 27, 2006 10 54 AM
`To: sarah.malka@valois.com
`Cc: Spivey Richard; Coniglio Tony; Edick Paul; Fishman Corey
`Subject: Pfeiffer Bi Dose Nasal Spray System
`
`Sarah,
`At our meeting on February 6th could you give your brief perspective on the Pfeiffer's Bi Dose Nasal System and the types of products this
`device is used for, just so that we can assess whether this could be something worth exploring in the future?
`Could you also explain to us how the coordination of activities in the AptarGroup are actually working. Are there separate sales
`representatives? Would a supply agreement cover the total AptarGroup or just the Valois division?
`
`Thanks.
`Best regards,
`Dennis
`
`HIGHLY CONFIDENTIAL-
`SUBJECT TO STIPULATED PROTECTIVE ORDER
`
`PLAINTIFFS'
`TRIAL EXHIBIT
`PTX0149
`
`MEDA_APTX01884280
`
`PTX0149-00001
`
`1
`
`CIP2057
`Argentum Pharmaceuticals LLC v. Cipla Ltd.
`IPR2017-00807
`
`